• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. 17th Annual BIO CEO & Investor Conference to Feature Congressional Leaders, Institutional Investors, Industry Analysts and Senior Biotechnology Executives

    17th Annual BIO CEO & Investor Conference to Feature Congressional Leaders, Institutional Investors, Industry Analysts and Senior Biotechnology Executives

  2. CORRECTING and REPLACING Pernix Therapeutics Exceeds 2014 Revenue Guidance: Delivers FY2014 Net Revenue In Excess of $120 Million

    CORRECTING and REPLACING Pernix Therapeutics Exceeds 2014 Revenue Guidance: Delivers FY2014 Net Revenue In Excess of $120 Million

  3. Pernix Therapeutics Announces FDA Acceptance With Priority Review of Its TREXIMET® sNDA for Use in Adolescent Patients

    Pernix Therapeutics Announces FDA Acceptance With Priority Review of Its TREXIMET® sNDA for Use in Adolescent Patients

  4. Research and Markets: Myanmar Healthcare Report: A Look Into Myanmar's Emerging $480 Million Healthcare Sector

    Research and Markets: Myanmar Healthcare Report: A Look Into Myanmar's Emerging $480 Million Healthcare Sector

  5. Research and Markets: Brazil Pharmaceutical Market Outlook 2018

    Research and Markets: Brazil Pharmaceutical Market Outlook 2018

  6. Isis Pharmaceuticals Appoints Sarah Boyce As Chief Business Officer

    Isis Pharmaceuticals Appoints Sarah Boyce As Chief Business Officer

  7. Isis Pharmaceuticals Announces Collaboration With Janssen to Discover and Develop RNA-Targeted Therapeutics for Autoimmune Diseases in the GI Tract

    Isis Pharmaceuticals Announces Collaboration With Janssen to Discover and Develop RNA-Targeted Therapeutics for Autoimmune Diseases in the GI Tract

  8. Our 2014 Big Pharma Pipeline Rankings: Who Came Out on Top?

    Merck's reinvigorated pipeline and Sanofi's minimal patent-loss exposure placed them atop our rankings this year, while GlaxoSmithKline joined Pfizer toward the bottom.

  9. Isis Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference

    Isis Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference

  10. Ultimate Stock-Pickers: Top 10 Buys and Sells

    Top managers continue to find new opportunities, while taking full advantage of a rising stock market to book some gains.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.